Latest News

Athens, Greece (UroToday.com) Dr. Roland Seiler presented after Dr. Andrea Necchi, supporting the role of chemotherapy in the neoadjuvant setting of treating muscle invasive bladder cancer (MIBC), as opposed to immunotherapy. Radical cystectomy is the gold standard for the treatment of MIBC. Ways of improving the prognosis of patients undergoing radical cystectomy include perfecting the technique […]

Athens, Greece (Urotoday.com) Focal therapy can be defined as treatment of a specific focus (targeted ablation or limited defined region -quadrant-ablation or hemi-ablation). This discussion focused on high-intensity focused ultrasound (HIFU) modality. This entails ultrasound waves delivered transrectally from a spherical transducer. The high-intensity waves converge to a focal point and cause hyperthermia and damage […]

Athens, Greece (UroToday.com) Dr. Andrea Necchi began the debate in this session supporting the role of immunotherapy over chemotherapy as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC). According to the EAU guidelines, neoadjuvant immunotherapy to patients should only be given in the setting of a clinical trial, while chemotherapy is recommended as the standard of […]

Athens, Greece (UroToday.com) Cryoablation involves freezing of the targeted prostate tissue in two cycles, reaching minus 40 degrees Celsius, with the following histological changes: Protein denaturation Direct rupture of cell membranes by crystal formation Vascular stasis and secondary microthrombi formation Ischemic cell death Coagulative necrosis Ten-year data of whole-gland cryoablation in 370 patients with a follow-up […]

Athens, Greece (Urotoday.com) Dr. Tan began this debate regarding the need for urinary biomarkers in the management of bladder cancer. According to Dr. Tan, urine biomarkers can be used for detection or for prognosis. There is a great need for them in bladder cancer, but especially in surveillance of non-muscle invasive bladder cancer (NMIBC), and much […]